The two companies focus on research, development and commercialization of sterile packaged implants and surgical tools for spinal fusion.
Back 2 Basics Direct and Orbbö Surgical represent Wishbone Medical’s fifth and sixth acquisitions in the past 18 months, according to an Aug. 5 announcement.
The acquisitions add nine FDA-cleared spinal fusion products to Wishbone Medical’s portfolio, which is expected to bring more than $12 million in year one revenue for the company.
Twenty spine-focused employees will be added to Wishbone Medical’s global team of 165.
More articles on devices:
Acquisitions, leadership changes & more: 6 big moves from Medtronic
Zimmer Biomet’s worldwide knee sales plummet 46.8% in Q2, hitting $374M
9 spine surgeons stepping into new leadership roles
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.